KOWA CO.,LTD. Logo

KOWA CO.,LTD.

A diversified manufacturer and trader in healthcare, optical products, and hospitality.

7807 | T

Overview

Corporate Details

ISIN(s):
JP3292900002
LEI:
Country:
Japan
Address:
堺市堺区海山町3丁159番地1

Description

Kowa Co., Ltd. is a diversified company that integrates manufacturing and trading operations across several business units. The company's trading arm manages the import, export, and sale of a wide range of products, including textiles, machinery, and construction materials. In the life science and healthcare sector, Kowa develops, manufactures, and markets pharmaceuticals, over-the-counter health products, and medical devices, with a notable specialization in ophthalmic diagnostic equipment. The company is also a prominent manufacturer of high-performance optical products, such as binoculars and spotting scopes, under its Prominar brand. Additionally, Kowa operates a hospitality business, managing hotels and other related services.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-15 08:35
確認書
Japanese 8.1 KB
2025-10-15 08:34
半期報告書-第39期(2025/03/01-2026/02/28)
Japanese 199.0 KB
2025-06-05 07:08
確認書
Japanese 8.1 KB
2025-06-05 07:07
訂正有価証券報告書-第38期(2024/03/01-2025/02/28)
Japanese 633.3 KB
2025-05-29 09:21
内部統制報告書-第38期(2024/03/01-2025/02/28)
Japanese 23.1 KB
2025-05-29 09:17
確認書
Japanese 8.0 KB
2025-05-29 09:14
有価証券報告書-第38期(2024/03/01-2025/02/28)
Japanese 1.0 MB
2025-05-29 09:06
臨時報告書
Japanese 22.4 KB
2025-01-10 03:50
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 23.1 KB
2024-12-06 08:00
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.9 KB
2024-11-29 07:03
確認書
Japanese 8.1 KB
2024-11-29 07:02
半期報告書-第38期(2024/03/01-2025/02/28)
Japanese 201.4 KB
2024-11-13 05:58
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.2 KB
2024-10-09 07:36
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.6 KB
2024-09-19 06:17
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 20.7 KB

Automate Your Workflow. Get a real-time feed of all KOWA CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KOWA CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KOWA CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.